Circulating Tumour DNA (ctDNA) as a Predictor of Clinical Outcome in Non-Small Cell Lung Cancer Undergoing Targeted Therapies: A Systematic Review and Meta-Analysis

SIMPLE SUMMARY: Liquid biopsies have revolutionised the diagnostic and therapeutic landscape of non-small cell lung cancer (NSCLC), where several distinct genomic subtypes exist. Measuring such circulating biomarkers in serum/plasma is a feasible alternative to tissue biopsy, but the full clinical u...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaman, Farzana Y., Subramaniam, Ashwin, Afroz, Afsana, Samoon, Zarka, Gough, Daniel, Arulananda, Surein, Alamgeer, Muhammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177293/
https://www.ncbi.nlm.nih.gov/pubmed/37173891
http://dx.doi.org/10.3390/cancers15092425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177293/
https://www.ncbi.nlm.nih.gov/pubmed/37173891
http://dx.doi.org/10.3390/cancers15092425

Ejemplares similares